EUVIMEDEUVIMED entdecken
Open Access

MARCH8 downregulation modulates profibrotic responses including myofibroblast differentiation

Xia Guo, Oluwaseun Adeyanju iD, Ayobami Matthew Olajuyin, Venkatakirankumar Mandlem iD, Christudas Sunil, Joy Adewumi, Steven Huang iD, Torry A Tucker iD, Steven Idell iD, Guoqing Qian iD

American Journal of Physiology-Cell Physiology · 01.11.2023 · 325 (5) · C1190-C1200

DOI: 10.1152/ajpcell.00166.2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.11.2023. Verfasst von Xia Guo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, Texas, United States. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Lung Diseases, Interstitial. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MARCH8 is an important modulator of inflammation, immunity, and other cellular processes. We found that MARCH8 expression is downregulated in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and experimental models of pulmonary fibrosis. Furthermore, TGF-β1 decreases MARCH8 transcriptionally in human lung fibroblasts (HLFs). MARCH8 overexpression blunts TGF-β1-induced fibroblast to myofibroblast transition while knockdown of MARCH8 drives this profibrotic change in HLFs. The findings support further exploration of MARCH8 as a novel target in IPF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisLung Diseases, InterstitialHumansTransforming Growth Factor beta1MyofibroblastsDown-RegulationLungFibroblastsTransforming Growth Factor betaBleomycinInflammationRNA, Messenger

Stichwörter der Autor:innen

IPFMARCH8TGF-βfibroblastlung

Substanzen

Transforming Growth Factor beta1Transforming Growth Factor betaBleomycinRNA, Messenger

Autor:innen und Institutionen

  • Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, Texas, United States.
  • The Texas Lung Injury Institute, The University of Texas Health Science Center at Tyler, Tyler, Texas, United States.

ORCID-Profile: Oluwaseun Adeyanju, Venkatakirankumar Mandlem, Steven Huang, Torry A Tucker, Steven Idell, Guoqing Qian

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • National Institutes of Health
  • University of Texas Health Science Center at Tyler

Zitieren

APA

Guo, X., Adeyanju, O., Olajuyin, A. M., Mandlem, V., Sunil, C., Adewumi, J., Huang, S., Tucker, T. A., Idell, S., & Qian, G. (2023). MARCH8 downregulation modulates profibrotic responses including myofibroblast differentiation. American Journal of Physiology-Cell Physiology, 325(5), C1190-C1200. https://doi.org/10.1152/ajpcell.00166.2023

Vancouver

Guo X, Adeyanju O, Olajuyin AM, Mandlem V, Sunil C, Adewumi J, et al. MARCH8 downregulation modulates profibrotic responses including myofibroblast differentiation. American Journal of Physiology-Cell Physiology. 2023;325(5):C1190-C1200. doi:10.1152/ajpcell.00166.2023

BibTeX
@article{Guo2023,
  author = {Guo, Xia and Adeyanju, Oluwaseun and Olajuyin, Ayobami Matthew and Mandlem, Venkatakirankumar and Sunil, Christudas and Adewumi, Joy and Huang, Steven and Tucker, Torry A and Idell, Steven and Qian, Guoqing},
  title = {MARCH8 downregulation modulates profibrotic responses including myofibroblast differentiation},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2023},
  volume = {325},
  number = {5},
  pages = {C1190--C1200},
  doi = {10.1152/ajpcell.00166.2023}
}
Kostenlos starten →